-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
2020 January 21, 2019 United States confirmed the first case of coronavirus disease ( COVID-19 )
.
On March 19, 2020, California was the first state to issue a stay-at-home order, and most states issued similar orders in the following months
COVID-19
Recently, a research article published in Diabetes Care, an authoritative journal in the field of diabetes , aims to evaluate the changes in the prevalence of depression, loneliness and insomnia in elderly patients with type 2 diabetes from 2016 to 2020, and to evaluate these Disease risk factors, including demographics, frequent incidence, BMI, treatment group, and pre-COVID-19 measurement scores
.
This is a prospective, observational study with participants from the LookAHEAD (Diabetes Health Action) cohort study
.
The data comes from two assessments before COVID-19 (V1: April 2016 to June 2018 and V2: February 2018 to February 2020) and one assessment during COVID-19 (V3: July 2020 Month to December)
The study included 2829 adults (63.
2% were women, 60.
6% were white, and the average [SD] age was 75.
6 [6.
0] years)
.
Between the two pre-pandemic visits, the prevalence of mild or severe depressive symptoms did not change significantly (P=0.
It can be seen that during the COVID-19 period, the prevalence of mild or severe depressive symptoms among elderly people with diabetes is more than 1.
6 times that of before the pandemic
.
6 times higher than before the pandemic
.
Original Source:
Ariana M.
Chao,et al.
Changes in the Prevalence of Symptoms of Depression, Loneliness, and Insomnia in US Older Adults With Type 2 Diabetes During the COVID-19 Pandemic: The Look AHEAD Study .
Original Source: Changes in at The Prevalence of Symptoms of Depression, Loneliness, and US Insomnia in Older Adults With Type 2 Diabetes During COVID-19 at The Pandemic: the AHEAD Look at The Study in this message
